Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study

By afschroeder • March 26, 2026

Fleseriu M, Biller BMK, Webb SM, Strasburger CJ, Georgescu CE, Bidlingmaier M, Wang C, Baciu I, Casanueva FF, Gilis-Januszewska A, Hart G, Manners A, Choe J, Bar-Ilan A, Carlsson M, Torre D, Taylor CT, Yuen KCJ. Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study. Pituitary. 2026 Mar 25;29(2):59. doi: 10.1007/s11102-026-01661-1. PMID: 41879875.

Tags: Adult growth hormone deficiency, body composition, Endocrinology, Harbor UCLA, IGF-I, Lean body mass, Long-acting growth hormone, Publications, Somatrogon

Safety and Efficacy of Repeat Surgery for Recurrent Craniopharyngiomas: A RAPID Consortium Collaboration

Shih RM, Harary M, Bergsneider M, Wang M, Heaney AP, Wu KC, Prevedello DM, Evans JJ, Chicoine MR, Kim AH, Silverstein JM, Karsy M, Van[...]

Longitudinal Outcomes in Immune Checkpoint Inhibitor-Associated Uveitis

Yun JS, Feo A, Chew L, Feng J, Hutchins E, Stein-Merlob AF, Yang EH, Lechner MG, Tsui E. Longitudinal Outcomes in Immune Checkpoint Inhibitor-Associated Uveitis.[...]

Development of insulin resistance in women over the menopause transition

Karlamangla AS, Han WJ, Srikanthan P, Shieh A, Thomas D, Sternfeld B, Hedderson MM, Greendale GA. Development of insulin resistance in women over the menopause[...]